Susquehanna International Group, LLP Centogene N.V. Transaction History

Susquehanna International Group, LLP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.72 - $1.28 $1,097 - $1,950	1,524 Added 13.92%	12,473 $11,000
Q3 2022 Nov 14, 2022	BUY	$1.11 - $2.78 $12,153 - $30,438	10,949 New	10,949 $14,000

33.6K

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.